Severe chronic neutropenia is characterized by a reduction over several months of absolute neutrophil counts. Bacterial infections, including deep tissue infections, sepsis and fever occur very frequently in these patients. Congenital, cyclic and idiopathic neutropenia are principal categories of severe chronic neutropenia. Among them, severe congenital neutropenia (SCN) was first described by Kostmann in 1956 in a large intermarried Swedish family as infantile agranulocytosis with autosomal recessive inheritance. 1 It is now well known that SCN is genetically heterogeneous with most cases arising sporadically. 2 Mutations in neutrophil elastase, ELA2, are present in the DNA extracted from the peripheral blood of 35-84% of SCN cases. 2 The subset of SCN patients with ELA2 mutation present with more severe disease symptoms including lower neutrophil counts, requirement for higher doses of G-CSF to achieve a response and also a higher rate of neoplastic progression. 2 Here, we report a case of a 3 month-old girl who was admitted to our hospital with a history of persisting fever and chronic otitis media, persisting after a 2 week course of antibiotic therapy. Upon admittance, physical examination showed fever, bilateral otitis media and hepatomegaly. A complete blood count showed a white cell count (WBC) of 8.4 Â 10 9 /l, hemoglobin level at 10.8 g/dl and a platelet count at 553 Â 10 9 /l. The differential WBC count showed 0 neutrophil, 6.3 Â 10 9 /l lymphocytes and 2.1 Â 10 9 /l monocytes. Analysis of liver enzyme activity showed elevated aspartate aminotransferase (64 U/l -normal range 11-35 U/l) and alanine aminotransferase (51 U/l -normal range 5-43 U/l). Bilirubin levels were however normal. C-reactive protein (CRP) levels were extremely elevated (320 mg/l -normal o4 mg/l). Blood and stool cultures as well as viral serologies (EBV, CMV, HIV, HCV, HBV) were negative. Intravenous antibiotic therapy led to apyrexy and a reduction to normal liver size after 18 days, but agranulocytosis remained unchanged.
Bone marrow aspiration was performed and revealed normal megakaryocytes and erythroid precursors. Myeloid development, however, was altered, exhibiting maturation arrest at the promyelocyte stage. Analysis of the ELA2 gene sequence revealed heterozygous mutation in neutrophil elastase, thus confirming the diagnosis of SCN. G-CSF therapy was initiated and continued, with dosing gradually increased up to 50 mg/kg/day. Despite this, the neutrophil count did not improve. Additionally, several courses of antibiotic therapies were administered. Significantly, cessation of antibiotic therapy in every case resulted in fever and increase in CRP. It was concluded that bone marrow transplantation (BMT) was the only curative treatment option.
Pretransplant evaluation included positron emission tomography (PET) with 130 MBq 18 F-fluorodeoxyglucose (FDG). Abnormal FDG uptake was detected in the V segment of the liver (Figure 1 ). Abdominal computed tomography (CT) showed a hypodense mass (25 mm Â 30 mm) and an endoscopy-assisted biopsy was performed. The mass was characterized by proliferation of fibroblast-like spindle cells with diffuse infiltration of plasma cells and lymphocytes. Stains and cultures for bacteria and fungi were negative.
The results were most consistent with microbiologic etiology and therefore both antibiotic and antifungal treatment were administered for a prolonged period of time (21 days). After 21 days, a second PET scan was performed, demonstrating a similar abnormal FDG uptake. Again, a percutaneous echo-guided needle biopsy of the mass was consistent with a diagnosis of inflammatory pseudotumor of the liver.
Hepatic lobectomy was declined owing to the risks of the procedure and it was decided that the patient receive white blood cell transfusions. The first one was performed with radiolabeled 99m Tc-HMPAO-WBC and showed concentration in the IPTL. After three WBC transfusions, a third FDG PET scan was performed and showed decreased FDG uptake by the lesion. BMT was then undertaken.
The child received a combination chemotherapy of busulfan (20 mg/kg), cyclophosphamide (200 mg/kg) and antithymocyte globulin (20 mg/kg). Stem cells were derived from the patient's HLA-identical sibling. 7.16 Â 10 8 nucleated cells/kg were infused. Following transplantation, prophylaxis for graft-versus-host (GVH) disease consisted of cyclosporin A alone. Antibiotics and antifungal therapy were administered during chemotherapy and neutropenia. G-CSF was administered on day 5 after BMT and WBC transfusions were added on day 5, 7 and 9 post BMT. The neutrophil count reached 0.5 Â 10 9 /l on day 10 and the platelet count reached 50 Â 10 9 /l on day 20. At 25 days post implantation, chimerism study showed 100% donor cells. The child did not develop acute or chronic GVH disease, neither did she develop any opportunistic or life-threatening infections.
At day 42, the patient underwent a fourth FDG PET showing normal FDG uptake. After 8 months post procedure, the patient shows no signs of disease and is doing well.
In SCN patients, the neutropenia causes recurrent and often severe lethal infections in the first years of life. 3 Survival and quality of life have been dramatically improved by G-CSF treatment: more than 90% of patients are responsive to G-CSF with increased neutrophil count and reduced infections. 3 For patients who do not respond to G-CSF therapy, BMT is the only curative treatment option. 4 Every effort should be made to ensure patients are without evidence of infection before entering a transplantation procedure. The use of FDG PET is a novel and comprehensive technique for initial whole-body screening for a neutropenic patient with fever of unknown origin. It has several advantages over other imaging modalities for patient assessment in these cases. First, compared to FDG PET, CT or magnetic resonance imaging (MRI) is of variable sensitivity for infectious lesions during neutropenia and, second, FDG PET provides a quantitative assessment of physiological parameters with the lesion, whereas CT and MRI do not. 5 FDG PET is, therefore, very useful to define the extent of disease and to monitor the response to treatment over the time.
Inflammatory pseudotumor is a rare benign condition that has been found in various organs, including the liver. Histologic findings include proliferation of connective tissue with chronic inflammatory cell infiltration by plasma cells, lymphocytes and histiocytes. 6 To date, about 20 pediatric cases of IPTL have been reported. [6] [7] [8] [9] Two of them were associated with neutrophil disorders (one Kostmann's 6 and one Papillon-Lefevre syndrome 9 ). This lesion is generally regarded as a benign reactive inflammatory condition. No microbiologic etiology has been found. IPTL may derive from a combination of repeated infections and an incomplete immune response resulting in a chronic inflammatory reaction and pseudotumor formation. 6 In the case presented here, there were no characteristic or diagnostic findings on US, CT or MRI. In order to achieve a definitive diagnosis, it was necessary to perform a US-or CT-guided needle biopsy.
In most cases, pseudotumor is resected. In our case, leukocyte transfusions showed partial efficiency and the disease together with neutropenia disappeared after BMT.
In patients with SCN refractory to G-CSF and antibiotics, BMT is the only curative treatment. Infection and/ or inflammatory lesions should not be a contraindication for BMT provided they are well documented and treated before BMT. Letter to the Editor
